A single arm phase Ib/II trial of first-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancer

Choong‐kun Lee(Yonsei University), Hyun Cheol Chung(Yonsei University Health System)
Nature Communications
October 12, 2022
Cited by 53


Related Papers